KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Enterprise Value Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -4.32%
Dec 31, 2025 -4.98%
Sep 30, 2025 -22.44%
Jun 30, 2025 -0.96%
Mar 31, 2025 7.69%
Dec 31, 2024 13.86%
Sep 30, 2024 19.82%
Jun 30, 2024 20.03%
Mar 31, 2024 9.25%
Dec 31, 2023 8.14%
Sep 30, 2023 28.77%
Jun 30, 2023 26.22%
Mar 31, 2023 20.40%
Dec 31, 2022 15.59%
Sep 30, 2022 34.86%
Jun 30, 2022 23.36%
Mar 31, 2022 -19.81%
Dec 31, 2021 -24.97%
Sep 30, 2021 -32.39%
Jun 30, 2021 -29.27%
Mar 31, 2021 -24.55%
Dec 31, 2020 -13.68%
Sep 30, 2020 -44.48%
Jun 30, 2020 -50.11%
Mar 31, 2020 -44.99%
Dec 31, 2019 -35.26%
Sep 30, 2019 -81.87%
Jun 30, 2019 -86.76%
Mar 31, 2019 -27.89%
Dec 31, 2018 -28.20%
Sep 30, 2018 -8.79%
Jun 30, 2018 -4.02%
Mar 31, 2018 3.74%
Dec 31, 2017 -13.69%
Sep 30, 2017 0.81%
Jun 30, 2017 3.59%
Mar 31, 2017 5.07%
Dec 31, 2016 -11.63%
Sep 30, 2016 -25.41%
Jun 30, 2016 -17.10%
Mar 31, 2016 -18.44%
Dec 31, 2015 -13.48%
Sep 30, 2015 -21.22%
Jun 30, 2015 0.09%
Mar 31, 2015 -13.39%
Dec 31, 2014 6.10%
Sep 30, 2014 4.90%
Jun 30, 2014 3.30%
Mar 31, 2014 -0.53%
Dec 31, 2013 15.55%
Sep 30, 2013 37.87%
Jun 30, 2013 33.70%
Mar 31, 2013 32.29%
Dec 31, 2012 31.02%
Sep 30, 2012 30.77%
Jun 30, 2012 17.79%
Mar 31, 2012 -80.54%